The American Medical Association today adopted a policy declaring drug shortages an urgent public health crisis. As part of the policy, AMA will urge the Department of Health and Human Services and the Department of Homeland Security to examine drug shortages as a national security initiative, and call for greater manufacturer transparency regarding production location and problems and more information on the quality of outsourcing compounding facilities. The policy supports recommendations issued last year by the American Society of Healthy-System Pharmacists, AHA and other organizations as part of a drug shortages roundtable.   

Related News Articles

Headline
Reps. Scott Peters, D-Calif., Eliot Engel, D-N.Y., Brett Guthrie, R-KY, Anna Eshoo, D-Calif., Richard Hudson, R-N.C., Michael McCaul, R-Texas, Kurt Schrader, D…
Headline
The Food and Drug Administration today released a proposed rule that would allow states and other non-federal government entities to establish programs to…
Headline
Pictured, from left to right: Peter Adamson, chair of the Children’s Oncology Group at the Children’s Hospital of Philadelphia; Brian Marden, chief…
Headline
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists and Institute for Safe…
Headline
The Food and Drug Administration approved a record high 1,171 generic drugs (935 full approvals and 236 tentative approvals) in fiscal year 2019, the agency…
Headline
The AHA and six other organizations today submitted comments to the Drug Enforcement Administration on its proposed rule regarding controlled substances quotas…